Clinical trial of comparison of effectiveness of Omega-3 supplement on PCOS and metabolic syndrome with placebo

Phase 3

Conditions: Condition 1: Polycystic ovarian syndrome. Condition 2: menstural disorder. Condition 3: metabolic syndrom. Condition 4: hyperandrogenism. Condition 5: hirsutism.
Sclerocystic ovary syndrome Stein-Leventhal syndrome
hypomenorrea Nos, bleeding NOs, periods NOS
metabolic disorder unspecified
hyper secretion of ovarian androgen
genital hair exess in female
n92.6 , n9

Registration Number: IRCT201604193924N3

Lead Sponsor: Vice chancllor for Isfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 88

Inclusion Criteria

inclusion criteria: Patients who have informed consent ; PCOS disease, according to the NIH3 ; age between 18-40 ; Exclusion criteria: smoking, use of oral pregnancy pill or alcohol or fish oil in 3 month ago or into the study ; pregnancy; have disease of kidney or liver or heart or thyroid ; diabetes ; hyperprolactinemia ; Cushing, Adrenal congenital hyperplasia, menopause ; the patient withdrew into the study ; Failure to follow the next visit

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual disorders. Timepoint: 6 mounth afther implementation study. Method of measurement: questionnaire of Bleeding volume, number of days of spotting, Menstrual periods.;Body mass index. Timepoint: 6 mounth afther implementation study. Method of measurement: Weight in kilograms divided by the square of height in meters.;Hirsutism. Timepoint: 6 mounth afther implementation study. Method of measurement: Ferrimen- Gullway score.

Secondary Outcome Measures

Name	Time	Method
Abdominal circumference. Timepoint: and 6 mounths after implemention of study. Method of measurement: The size of the margin around the narrowest part of the lower ribs and the iliac crest at the end of a normal exhalation.;Hip circumference. Timepoint: 6 mounths after implemention of study. Method of measurement: Hip circumference on the line that connects the two greater trochanter.;Fasting blood sugare. Timepoint: 6 mounths after implemention of study. Method of measurement: blood glucose levels after 8 hours fasting.